Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 3
2015 9
2016 30
2017 21
2018 21
2019 13
2020 11
2021 7
2022 4
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 26966547

101 results

Results by year

Filters applied: . Clear all
Page 1
Safety and effectiveness of a 12-week course of sofosbuvir and simeprevir ± ribavirin in HCV-infected patients with or without HIV infection: a multicentre observational study.
Bruno G, Saracino A, Fabrizio C, Scudeller L, Milano E, Dell'Acqua R, Ladisa N, Fasano M, Minniti S, Buccoliero G, Tartaglia A, Giammario A, Milella M, Angarano G. Bruno G, et al. Int J Antimicrob Agents. 2017 Mar;49(3):296-301. doi: 10.1016/j.ijantimicag.2016.11.030. Epub 2017 Feb 2. Int J Antimicrob Agents. 2017. PMID: 28163136
Real-world cure rates for hepatitis C virus treatments that include simeprevir and/or sofosbuvir are comparable to clinical trial results.
Bichoupan K, Tandon N, Crismale JF, Hartman J, Del Bello D, Patel N, Chekuri S, Harty A, Ng M, Sigel KM, Bansal MB, Grewal P, Chang CY, Leong J, Im GY, Liu LU, Odin JA, Bach N, Friedman SL, Schiano TD, Perumalswami PV, Dieterich DT, Branch AD. Bichoupan K, et al. World J Virol. 2017 Nov 12;6(4):59-72. doi: 10.5501/wjv.v6.i4.59. World J Virol. 2017. PMID: 29147645 Free PMC article.
Real-World Sustained Virologic Response Rates of Sofosbuvir-Containing Regimens in Patients Coinfected With Hepatitis C and HIV.
Del Bello D, Cha A, Sorbera M, Bichoupan K, Levine C, Doyle E, Harty A, Patel N, Ng M, Gardenier D, Odin J, Schiano TD, Fierer DS, Berkowitz L, Perumalswami PV, Dieterich DT, Branch AD. Del Bello D, et al. Clin Infect Dis. 2016 Jun 15;62(12):1497-1504. doi: 10.1093/cid/ciw119. Epub 2016 Mar 1. Clin Infect Dis. 2016. PMID: 26936665 Free PMC article.
Effectiveness and safety of sofosbuvir/velpatasvir ± ribavirin vs glecaprevir/pibrentasvir in genotype 3 hepatitis C virus infected patients.
Margusino-Framiñán L, Cid-Silva P, Rotea-Salvo S, Mena-de-Cea Á, Suárez-López F, Vázquez-Rodríguez P, Delgado-Blanco M, Sanclaudio-Luhia AI, Martín-Herranz I, Castro-Iglesias Á. Margusino-Framiñán L, et al. Eur J Hosp Pharm. 2020 Mar;27(e1):e41-e47. doi: 10.1136/ejhpharm-2019-002060. Epub 2020 Feb 7. Eur J Hosp Pharm. 2020. PMID: 32296504 Free PMC article.
101 results